 Proactive Investors USA & Canada [1] |
Transition reaches licensing deal with Eli Lilly [2]
Reuters Lilly retains this option until the end of Phase II, and that if Lilly exercises these rights, Transition will receive milestone payments of about $250 … Transition Therapeutics acquires rights to diabetes compounds from Eli Lilly [1]Proactive Investors USA & Canada Transition Therapeutics Announces Licensing and Collaboration Agreement With Lilly [3]CNNMoney.com (press release) all 53 news articles » [4] |
More details can be found at www.diabeteshowto.com [5]